[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Metabolomics Market Growth (Status and Outlook) 2024-2030

January 2024 | 103 pages | ID: G79113BF91A2EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Metabolomics market size was valued at US$ 2089.5 million in 2023. With growing demand in downstream market, the Metabolomics is forecast to a readjusted size of US$ 5033.4 million by 2030 with a CAGR of 13.4% during review period.

The research report highlights the growth potential of the global Metabolomics market. Metabolomics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Metabolomics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Metabolomics market.

The key manufacturers of Metabolomics include Thermo Fisher, Agilent, Metabolon, Shimadzu, Corporation, Bruker, Waters Corporation, etc. Among them, Thermo Fisher and Agilent rank first and second in the world market share, about 12% and 9% respectively.

The market of metabolomics is distributed all over the world, with North America, Europe and Asia Pacific as the major markets. The North American market share reached more than 40%, ranking first in the world.

In terms of product, it include Metabolomics Instruments as well as Bioinformatics Tools and Services. The world market share of the two parts is about 2:1. It is expected that Bioinformatics Tools and Services' market share will increase relatively in the future.

Metabolomics is mainly used in academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and other institutional organizations. Among them, academic and research institutions occupy the highest market share, accounting for more than 45%. In the Chinese market, the share of academic and research institutions has reached more than 50%.

Key Features:

The report on Metabolomics market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Metabolomics market. It may include historical data, market segmentation by Type (e.g., Metabolomics Instruments, Bioinformatics Tools and Services), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Metabolomics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Metabolomics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Metabolomics industry. This include advancements in Metabolomics technology, Metabolomics new entrants, Metabolomics new investment, and other innovations that are shaping the future of Metabolomics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Metabolomics market. It includes factors influencing customer ' purchasing decisions, preferences for Metabolomics product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Metabolomics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Metabolomics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Metabolomics market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Metabolomics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Metabolomics market.

Market Segmentation:

Metabolomics market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value.

Segmentation by type
  • Metabolomics Instruments
  • Bioinformatics Tools and Services
Segmentation by end user
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Thermo Fisher
  • Agilent
  • Metabolon
  • Shimadzu Corporation
  • Bruker
  • Waters Corporation
  • Biotree
  • LECO Corporation
  • Biocrates Life Sciences AG
  • Human Metabolome Technologies
  • Metware
  • Applied Protein Technology
  • Creative Proteomics
  • Diagnostic Solutions Laboratory
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Metabolomics Market Size 2019-2030
  2.1.2 Metabolomics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Metabolomics Segment by Type
  2.2.1 Metabolomics Instruments
  2.2.2 Bioinformatics Tools and Services
2.3 Metabolomics Market Size by Type
  2.3.1 Metabolomics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Metabolomics Market Size Market Share by Type (2019-2024)
2.4 Metabolomics Segment by End User
  2.4.1 Academic and Research Institutes
  2.4.2 Pharmaceutical and Biotechnology Companies
  2.4.3 Contract Research Organizations
2.5 Metabolomics Market Size by End User
  2.5.1 Metabolomics Market Size CAGR by End User (2019 VS 2023 VS 2030)
  2.5.2 Global Metabolomics Market Size Market Share by End User (2019-2024)

3 METABOLOMICS MARKET SIZE BY PLAYER

3.1 Metabolomics Market Size Market Share by Players
  3.1.1 Global Metabolomics Revenue by Players (2019-2024)
  3.1.2 Global Metabolomics Revenue Market Share by Players (2019-2024)
3.2 Global Metabolomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 METABOLOMICS BY REGIONS

4.1 Metabolomics Market Size by Regions (2019-2024)
4.2 Americas Metabolomics Market Size Growth (2019-2024)
4.3 APAC Metabolomics Market Size Growth (2019-2024)
4.4 Europe Metabolomics Market Size Growth (2019-2024)
4.5 Middle East & Africa Metabolomics Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Metabolomics Market Size by Country (2019-2024)
5.2 Americas Metabolomics Market Size by Type (2019-2024)
5.3 Americas Metabolomics Market Size by End User (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Metabolomics Market Size by Region (2019-2024)
6.2 APAC Metabolomics Market Size by Type (2019-2024)
6.3 APAC Metabolomics Market Size by End User (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Metabolomics by Country (2019-2024)
7.2 Europe Metabolomics Market Size by Type (2019-2024)
7.3 Europe Metabolomics Market Size by End User (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Metabolomics by Region (2019-2024)
8.2 Middle East & Africa Metabolomics Market Size by Type (2019-2024)
8.3 Middle East & Africa Metabolomics Market Size by End User (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL METABOLOMICS MARKET FORECAST

10.1 Global Metabolomics Forecast by Regions (2025-2030)
  10.1.1 Global Metabolomics Forecast by Regions (2025-2030)
  10.1.2 Americas Metabolomics Forecast
  10.1.3 APAC Metabolomics Forecast
  10.1.4 Europe Metabolomics Forecast
  10.1.5 Middle East & Africa Metabolomics Forecast
10.2 Americas Metabolomics Forecast by Country (2025-2030)
  10.2.1 United States Metabolomics Market Forecast
  10.2.2 Canada Metabolomics Market Forecast
  10.2.3 Mexico Metabolomics Market Forecast
  10.2.4 Brazil Metabolomics Market Forecast
10.3 APAC Metabolomics Forecast by Region (2025-2030)
  10.3.1 China Metabolomics Market Forecast
  10.3.2 Japan Metabolomics Market Forecast
  10.3.3 Korea Metabolomics Market Forecast
  10.3.4 Southeast Asia Metabolomics Market Forecast
  10.3.5 India Metabolomics Market Forecast
  10.3.6 Australia Metabolomics Market Forecast
10.4 Europe Metabolomics Forecast by Country (2025-2030)
  10.4.1 Germany Metabolomics Market Forecast
  10.4.2 France Metabolomics Market Forecast
  10.4.3 UK Metabolomics Market Forecast
  10.4.4 Italy Metabolomics Market Forecast
  10.4.5 Russia Metabolomics Market Forecast
10.5 Middle East & Africa Metabolomics Forecast by Region (2025-2030)
  10.5.1 Egypt Metabolomics Market Forecast
  10.5.2 South Africa Metabolomics Market Forecast
  10.5.3 Israel Metabolomics Market Forecast
  10.5.4 Turkey Metabolomics Market Forecast
  10.5.5 GCC Countries Metabolomics Market Forecast
10.6 Global Metabolomics Forecast by Type (2025-2030)
10.7 Global Metabolomics Forecast by End User (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher
  11.1.1 Thermo Fisher Company Information
  11.1.2 Thermo Fisher Metabolomics Product Offered
  11.1.3 Thermo Fisher Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Thermo Fisher Main Business Overview
  11.1.5 Thermo Fisher Latest Developments
11.2 Agilent
  11.2.1 Agilent Company Information
  11.2.2 Agilent Metabolomics Product Offered
  11.2.3 Agilent Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Agilent Main Business Overview
  11.2.5 Agilent Latest Developments
11.3 Metabolon
  11.3.1 Metabolon Company Information
  11.3.2 Metabolon Metabolomics Product Offered
  11.3.3 Metabolon Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Metabolon Main Business Overview
  11.3.5 Metabolon Latest Developments
11.4 Shimadzu Corporation
  11.4.1 Shimadzu Corporation Company Information
  11.4.2 Shimadzu Corporation Metabolomics Product Offered
  11.4.3 Shimadzu Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Shimadzu Corporation Main Business Overview
  11.4.5 Shimadzu Corporation Latest Developments
11.5 Bruker
  11.5.1 Bruker Company Information
  11.5.2 Bruker Metabolomics Product Offered
  11.5.3 Bruker Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Bruker Main Business Overview
  11.5.5 Bruker Latest Developments
11.6 Waters Corporation
  11.6.1 Waters Corporation Company Information
  11.6.2 Waters Corporation Metabolomics Product Offered
  11.6.3 Waters Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Waters Corporation Main Business Overview
  11.6.5 Waters Corporation Latest Developments
11.7 Biotree
  11.7.1 Biotree Company Information
  11.7.2 Biotree Metabolomics Product Offered
  11.7.3 Biotree Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Biotree Main Business Overview
  11.7.5 Biotree Latest Developments
11.8 LECO Corporation
  11.8.1 LECO Corporation Company Information
  11.8.2 LECO Corporation Metabolomics Product Offered
  11.8.3 LECO Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 LECO Corporation Main Business Overview
  11.8.5 LECO Corporation Latest Developments
11.9 Biocrates Life Sciences AG
  11.9.1 Biocrates Life Sciences AG Company Information
  11.9.2 Biocrates Life Sciences AG Metabolomics Product Offered
  11.9.3 Biocrates Life Sciences AG Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Biocrates Life Sciences AG Main Business Overview
  11.9.5 Biocrates Life Sciences AG Latest Developments
11.10 Human Metabolome Technologies
  11.10.1 Human Metabolome Technologies Company Information
  11.10.2 Human Metabolome Technologies Metabolomics Product Offered
  11.10.3 Human Metabolome Technologies Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Human Metabolome Technologies Main Business Overview
  11.10.5 Human Metabolome Technologies Latest Developments
11.11 Metware
  11.11.1 Metware Company Information
  11.11.2 Metware Metabolomics Product Offered
  11.11.3 Metware Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Metware Main Business Overview
  11.11.5 Metware Latest Developments
11.12 Applied Protein Technology
  11.12.1 Applied Protein Technology Company Information
  11.12.2 Applied Protein Technology Metabolomics Product Offered
  11.12.3 Applied Protein Technology Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Applied Protein Technology Main Business Overview
  11.12.5 Applied Protein Technology Latest Developments
11.13 Creative Proteomics
  11.13.1 Creative Proteomics Company Information
  11.13.2 Creative Proteomics Metabolomics Product Offered
  11.13.3 Creative Proteomics Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 Creative Proteomics Main Business Overview
  11.13.5 Creative Proteomics Latest Developments
11.14 Diagnostic Solutions Laboratory
  11.14.1 Diagnostic Solutions Laboratory Company Information
  11.14.2 Diagnostic Solutions Laboratory Metabolomics Product Offered
  11.14.3 Diagnostic Solutions Laboratory Metabolomics Revenue, Gross Margin and Market Share (2019-2024)
  11.14.4 Diagnostic Solutions Laboratory Main Business Overview
  11.14.5 Diagnostic Solutions Laboratory Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Metabolomics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Metabolomics Instruments
Table 3. Major Players of Bioinformatics Tools and Services
Table 4. Metabolomics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Metabolomics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Metabolomics Market Size Market Share by Type (2019-2024)
Table 7. Metabolomics Market Size CAGR by End User (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Metabolomics Market Size by End User (2019-2024) & ($ Millions)
Table 9. Global Metabolomics Market Size Market Share by End User (2019-2024)
Table 10. Global Metabolomics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Metabolomics Revenue Market Share by Player (2019-2024)
Table 12. Metabolomics Key Players Head office and Products Offered
Table 13. Metabolomics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Metabolomics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Metabolomics Market Size Market Share by Regions (2019-2024)
Table 18. Global Metabolomics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Metabolomics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Metabolomics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Metabolomics Market Size Market Share by Country (2019-2024)
Table 22. Americas Metabolomics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Metabolomics Market Size Market Share by Type (2019-2024)
Table 24. Americas Metabolomics Market Size by End User (2019-2024) & ($ Millions)
Table 25. Americas Metabolomics Market Size Market Share by End User (2019-2024)
Table 26. APAC Metabolomics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Metabolomics Market Size Market Share by Region (2019-2024)
Table 28. APAC Metabolomics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Metabolomics Market Size Market Share by Type (2019-2024)
Table 30. APAC Metabolomics Market Size by End User (2019-2024) & ($ Millions)
Table 31. APAC Metabolomics Market Size Market Share by End User (2019-2024)
Table 32. Europe Metabolomics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Metabolomics Market Size Market Share by Country (2019-2024)
Table 34. Europe Metabolomics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Metabolomics Market Size Market Share by Type (2019-2024)
Table 36. Europe Metabolomics Market Size by End User (2019-2024) & ($ Millions)
Table 37. Europe Metabolomics Market Size Market Share by End User (2019-2024)
Table 38. Middle East & Africa Metabolomics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Metabolomics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Metabolomics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Metabolomics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Metabolomics Market Size by End User (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Metabolomics Market Size Market Share by End User (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Metabolomics
Table 45. Key Market Challenges & Risks of Metabolomics
Table 46. Key Industry Trends of Metabolomics
Table 47. Global Metabolomics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Metabolomics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Metabolomics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Metabolomics Market Size Forecast by End User (2025-2030) & ($ Millions)
Table 51. Thermo Fisher Details, Company Type, Metabolomics Area Served and Its Competitors
Table 52. Thermo Fisher Metabolomics Product Offered
Table 53. Thermo Fisher Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Thermo Fisher Main Business
Table 55. Thermo Fisher Latest Developments
Table 56. Agilent Details, Company Type, Metabolomics Area Served and Its Competitors
Table 57. Agilent Metabolomics Product Offered
Table 58. Agilent Main Business
Table 59. Agilent Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Agilent Latest Developments
Table 61. Metabolon Details, Company Type, Metabolomics Area Served and Its Competitors
Table 62. Metabolon Metabolomics Product Offered
Table 63. Metabolon Main Business
Table 64. Metabolon Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Metabolon Latest Developments
Table 66. Shimadzu Corporation Details, Company Type, Metabolomics Area Served and Its Competitors
Table 67. Shimadzu Corporation Metabolomics Product Offered
Table 68. Shimadzu Corporation Main Business
Table 69. Shimadzu Corporation Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Shimadzu Corporation Latest Developments
Table 71. Bruker Details, Company Type, Metabolomics Area Served and Its Competitors
Table 72. Bruker Metabolomics Product Offered
Table 73. Bruker Main Business
Table 74. Bruker Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Bruker Latest Developments
Table 76. Waters Corporation Details, Company Type, Metabolomics Area Served and Its Competitors
Table 77. Waters Corporation Metabolomics Product Offered
Table 78. Waters Corporation Main Business
Table 79. Waters Corporation Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Waters Corporation Latest Developments
Table 81. Biotree Details, Company Type, Metabolomics Area Served and Its Competitors
Table 82. Biotree Metabolomics Product Offered
Table 83. Biotree Main Business
Table 84. Biotree Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Biotree Latest Developments
Table 86. LECO Corporation Details, Company Type, Metabolomics Area Served and Its Competitors
Table 87. LECO Corporation Metabolomics Product Offered
Table 88. LECO Corporation Main Business
Table 89. LECO Corporation Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. LECO Corporation Latest Developments
Table 91. Biocrates Life Sciences AG Details, Company Type, Metabolomics Area Served and Its Competitors
Table 92. Biocrates Life Sciences AG Metabolomics Product Offered
Table 93. Biocrates Life Sciences AG Main Business
Table 94. Biocrates Life Sciences AG Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Biocrates Life Sciences AG Latest Developments
Table 96. Human Metabolome Technologies Details, Company Type, Metabolomics Area Served and Its Competitors
Table 97. Human Metabolome Technologies Metabolomics Product Offered
Table 98. Human Metabolome Technologies Main Business
Table 99. Human Metabolome Technologies Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Human Metabolome Technologies Latest Developments
Table 101. Metware Details, Company Type, Metabolomics Area Served and Its Competitors
Table 102. Metware Metabolomics Product Offered
Table 103. Metware Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Metware Main Business
Table 105. Metware Latest Developments
Table 106. Applied Protein Technology Details, Company Type, Metabolomics Area Served and Its Competitors
Table 107. Applied Protein Technology Metabolomics Product Offered
Table 108. Applied Protein Technology Main Business
Table 109. Applied Protein Technology Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Applied Protein Technology Latest Developments
Table 111. Creative Proteomics Details, Company Type, Metabolomics Area Served and Its Competitors
Table 112. Creative Proteomics Metabolomics Product Offered
Table 113. Creative Proteomics Main Business
Table 114. Creative Proteomics Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Creative Proteomics Latest Developments
Table 116. Diagnostic Solutions Laboratory Details, Company Type, Metabolomics Area Served and Its Competitors
Table 117. Diagnostic Solutions Laboratory Metabolomics Product Offered
Table 118. Diagnostic Solutions Laboratory Main Business
Table 119. Diagnostic Solutions Laboratory Metabolomics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Diagnostic Solutions Laboratory Latest Developments

LIST OF FIGURES

Figure 1. Metabolomics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Metabolomics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Metabolomics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Metabolomics Sales Market Share by Country/Region (2023)
Figure 8. Metabolomics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Metabolomics Market Size Market Share by Type in 2023
Figure 10. Metabolomics in Academic and Research Institutes
Figure 11. Global Metabolomics Market: Academic and Research Institutes (2019-2024) & ($ Millions)
Figure 12. Metabolomics in Pharmaceutical and Biotechnology Companies
Figure 13. Global Metabolomics Market: Pharmaceutical and Biotechnology Companies (2019-2024) & ($ Millions)
Figure 14. Metabolomics in Contract Research Organizations
Figure 15. Global Metabolomics Market: Contract Research Organizations (2019-2024) & ($ Millions)
Figure 16. Global Metabolomics Market Size Market Share by End User in 2023
Figure 17. Global Metabolomics Revenue Market Share by Player in 2023
Figure 18. Global Metabolomics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Metabolomics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Metabolomics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Metabolomics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Metabolomics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Metabolomics Value Market Share by Country in 2023
Figure 24. United States Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Metabolomics Market Size Market Share by Region in 2023
Figure 29. APAC Metabolomics Market Size Market Share by Type in 2023
Figure 30. APAC Metabolomics Market Size Market Share by End User in 2023
Figure 31. China Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Metabolomics Market Size Market Share by Country in 2023
Figure 38. Europe Metabolomics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Metabolomics Market Size Market Share by End User (2019-2024)
Figure 40. Germany Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Metabolomics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Metabolomics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Metabolomics Market Size Market Share by End User (2019-2024)
Figure 48. Egypt Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Metabolomics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Metabolomics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Metabolomics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Metabolomics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Metabolomics Market Size 2025-2030 ($ Millions)
Figure 57. United States Metabolomics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Metabolomics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Metabolomics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Metabolomics Market Size 2025-2030 ($ Millions)
Figure 61. China Metabolomics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Metabolomics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Metabolomics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Metabolomics Market Size 2025-2030 ($ Millions)
Figure 65. India Metabolomics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Metabolomics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Metabolomics Market Size 2025-2030 ($ Millions)
Figure 68. France Metabolomics Market Size 2025-2030 ($ Millions)
Figure 69. UK Metabolomics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Metabolomics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Metabolomics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Metabolomics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Metabolomics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Metabolomics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Metabolomics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Metabolomics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Metabolomics Market Size 2025-2030 ($ Millions)
Figure 78. Global Metabolomics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Metabolomics Market Size Market Share Forecast by End User (2025-2030)


More Publications